Compound ID | 1052
Class: Aminoglycoside
Spectrum of activity: | Gram-negative |
Details of activity: | DNA Synthesis inhibitor |
Institute where first reported: | The UpJohn Company |
Year first mentioned: | 1976 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
Reason Dropped: | "lack of clinical promise" |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/10409115 |
Guide to Pharmacology: | feldamycin |
Citations: |
|